Analysing the Effects of the COVID-19 Pandemic on Medical Supply Chains in Commonwealth Countries

Narayanan, Badri; Vickers, Brendan; Ali, Salamat

doi:10.14217/501dd683-en

Cited by 2 publications

(2 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The COVID-19 pandemic has had a direct impact on the medication supply worldwide. 18 Since Nakkasah was under complete lockdown, there was a reduced supply of medications for other conditions, and this could have also contributed to the worsening of comorbid conditions, as highlighted by one of our study participants.…”

Section: Discussionmentioning

confidence: 93%

Experiences of COVID-19 Recovered Patients – A Qualitative Case Study from a Hotspot in Saudi Arabia

Alhajjaji

Kurdi

Faqeh

et al. 2021

Preprint

View full text Add to dashboard Cite

Background COVID-19 is highly contagious and can have fatal outcomes in the elderly and those with comorbidities. Social distancing is highly recommended by the World Health Organization to prevent the spread of the disease. However, it is difficult to maintain social distancing in highly populated areas where people live in close proximity. Such high-risk areas have the potential to become hotspots for the disease spread, should one person therein contract the disease. Nakkasah is one such area in the Makkah city of Saudi Arabia which has been a hotspot in this pandemic. This study aims to qualitatively explore the experiences of COVID-19 recovered patients residing in this area. Methods We employed semi-structured face-to-face interviews with people living in Nakkasah, above 18 years of age, and recovered from COVID-19. An interview guide was developed, validated, piloted, and minor changes were made. Two trained students conducted the interviews in the Arabic language in a semi-private area of the community center. The interviews were audio-recorded, with informed consent from interviewees, transcribed verbatim, and thematically analyzed later. Results Eleven eligible COVID-19 recovered people (two female and nine male) agreed to be interviewed, and their verbal informed consent was audio recorded. The mean interview time was 24 minutes. Thematic analysis generated 30 subthemes, which were categorized into seven overarching themes: information about COVID-19; life during COVID-19 illness; spreading of COVID-19; precautionary measures; interventions that helped in recovery; impact of COVID-19 on life; support received during COVID-19 illness. Conclusion Experiences of people from the hotspot who had recovered from COVID-19 highlighted how life had been like in the hotspot under lockdown especially with having been afflicted with the infection, factors that facilitated their recovery, and the way their lives were and have been affected due to COVID-19.

show abstract

Section: Discussionmentioning

confidence: 93%

Experiences of COVID-19 Recovered Patients – A Qualitative Case Study from a Hotspot in Saudi Arabia

Alhajjaji

Kurdi

Faqeh

et al. 2021

Preprint

View full text Add to dashboard Cite

show abstract

“…Meanwhile, the EU's weaker domain was PPP. Gopalakrishnan et al (2020) demonstrated that developed countries monopolize the production of high-tech medical equipment, whereas developing countries, such as China, conquer the PPP market. Medical supply exports among Commonwealth countries are dominated by developed countries, whereas developing countries remain the major importers.…”

Section: Literature Reviewmentioning

confidence: 99%

Comparative Advantage and Competitiveness of COVID-19-Related Medical Products Exporters

Idris¹,

Ismail²,

Ibrahim³

2022

JOC

View full text Add to dashboard Cite

The coronavirus disease (COVID-19) pandemic generated an upsurge in demand for medical products. Trade policy changes, including export restrictions and import reforms, have led to a shortage of medical products. The World Health Organization has recommended countries to encourage local production and identify various import sources for medical products to ensure sustainable healthcare capacity to combat the COVID-19 pandemic and any similar events in the future. This study aims to examine the comparative advantages and competitiveness in producing medical products among top exporters. The contribution of this study is the ability to identify various import sources specific to developing countries. From the exporter’s perspective, this study allows countries to recognize their existing competitive strengths in the medical products trade, allowing them to strategize and compete in the international markets of medical products. Using Balassa’s revealed comparative advantage index, this study analyzes 25 primary medical product exporters, identifying several countries with a comparative advantage in producing medical products. Medicines are primarily dominated by high-income countries, including Switzerland and Germany, whereas middle-income countries, such as China and Malaysia, are more specialized in medical supplies, medical equipment, and personal protective products. This finding provides a basis for policy formulation that can facilitate the process of building a sustainable healthcare capacity.

show abstract

Analysing the Effects of the COVID-19 Pandemic on Medical Supply Chains in Commonwealth Countries

Cited by 2 publications

References 6 publications

Experiences of COVID-19 Recovered Patients – A Qualitative Case Study from a Hotspot in Saudi Arabia

Experiences of COVID-19 Recovered Patients – A Qualitative Case Study from a Hotspot in Saudi Arabia

Comparative Advantage and Competitiveness of COVID-19-Related Medical Products Exporters

Contact Info

Product

Resources

About